Valspodar
Valspodar is an experimental cancer treatment and chemosensitizer. It is a derivative of ciclosporin D.
Its primary use is as an inhibitor of the efflux transporter P-glycoprotein. Previous studies in animal models have found it to be effective at preventing cancer cell resistance to chemotherapeutics, but these findings did not translate to clinical success.